← Back to Search

Group B1 for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Dr. Kevin Rod
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Osteo-arthritis of knee joint diagnosed through X-Ray evaluation
Moderate or sever level of pain due to knee osteoarthritis and no other known reason
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the outcome will be measured over a period of 6 weeks.
Awards & highlights

Study Summary

To evaluate a new, low intensity ultrasound device in the treatment of chronic pain due to osteoarthritis in the knee. Enhancing CBD oil penetration into joints by sonophoresis.

Eligible Conditions
  • Osteoarthritis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the outcome will be measured over a period of 6 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the outcome will be measured over a period of 6 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Intensity Measure

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Group B2Active Control1 Intervention
This group of patients will not receive high CBD oil to the affected joint.
Group II: Group B1Active Control1 Intervention
The first patient group will receive high CBD oil applied topically to the affected knee joint.
Group III: Group AActive Control1 Intervention
The first patient group will receive Low Intensity Ultrasound Therapy on the affected knee joint, using the CPI-LIPUS Device
Group IV: Group BPlacebo Group1 Intervention
Will be "treated" with an identical device whose ultrasound emitting capabilities has been nullified. This device appears to operate, including illumination of the operating light.

Find a Location

Who is running the clinical trial?

Dr. Kevin RodLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~15 spots leftby Mar 2025